Walleye Trading
TXMD icon

Walleye Trading’s TherapeuticsMD TXMD Stock Holding History

Walleye Trading’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$13K – 5565
2021
Q1 		$13K Buy
+200
New +$15.7K ﹤0.01% 4611
2018
Q3 		– Sell
-335
Closed -$103K – 5558
2018
Q2 		$104K Buy
335
+294
+717% +$89.8K ﹤0.01% 4029
2018
Q1 		$10K Buy
41
+14
+52% +$3.93K ﹤0.01% 4361
2017
Q4 		$8 Buy
+27
New +$7.52K ﹤0.01% 4250
2016
Q1 		– Sell
-58
Closed -$30K – 5849
2015
Q4 		$30K Buy
+58
New +$21.4K ﹤0.01% 4195

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Walleye Trading's TXMD Position: Q2 2021 in Review

Walleye Trading sold out of TherapeuticsMD (TXMD) in Q2 2021, closing a stake of 200 shares — an estimated $13K sold.

Walleye Trading first reported a position in TXMD in Q4 2015 and held it in 5 quarters. The position peaked at $104K in Q2 2018. 154 funds tracked by Wall St. Rank hold TXMD as of Q2 2021.

  • Walleye Trading reported no remaining TherapeuticsMD position as of Q2 2021 after selling out during the quarter.
  • Walleye Trading sold 200 TherapeuticsMD shares in Q2 2021, an estimated $13K.
  • Walleye Trading first reported a position in TherapeuticsMD in Q4 2015 and held it in 5 quarters.
  • Walleye Trading's TherapeuticsMD position peaked at $104K in Q2 2018.
  • 154 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2021.

Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.